Recurrent Malignant Uterine Corpus Neoplasm

general

The reemergence of a malignant uterine corpus neoplasm after a period of remission.

81

Centers

155

Active Trials

Cancer Funding

Specific Cancer Types(1)

NameCenters
Recurrent Uterine Corpus Sarcoma24

Top Centers for Recurrent Malignant Uterine Corpus Neoplasm(81)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.8
2
NCI Comprehensive
Active Research Program
65.8
3
NCI Comprehensive
Active Research Program
65.8
4
NCI Comprehensive
Active Research Program
65.8
5
NCI Comprehensive
Active Research Program
65.8
6
NCI Comprehensive
Active Research Program
65.8
7
NCI Comprehensive
Active Research Program
65.8
8
NCI Comprehensive
Active Research Program
65.8
9
NCI Comprehensive
Active Research Program
65.8
10
NCI Comprehensive
Active Research Program
65.8
11
NCI Comprehensive
Active Research Program
65.8
12
NCI Comprehensive
Active Research Program
65.8
13
NCI Clinical
Active Research Program
65.8
14
NCI Comprehensive
Active Research Program
65.8
15
Active Research Program
65.8
16
NCI Clinical
Active Research Program
65.8
17
NCI Comprehensive
Active Research Program
65.8
18
Active Research Program
65.8
19
NCI Clinical
Active Research Program
65.8
20
Active Research Program
65.8
21
Active Research Program
65.8
22
Active Research Program
65.8
23
Active Research Program
65.8
24
Active Research Program
65.8
25
Active Research Program
65.8
26
NCI Comprehensive
Active Research Program
52.0
27
NCI Comprehensive
Active Research Program
52.0
28
NCI Comprehensive
Active Research Program
52.0
29
NCI Comprehensive
Active Research Program
52.0
30
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
52.0
31
NCI Comprehensive
Active Research Program
52.0
32
NCI Comprehensive
Active Research Program
52.0
33
NCI Clinical
Active Research Program
52.0
34
NCI Comprehensive
Active Research Program
52.0
35
Active Research Program
52.0
36
NCI Comprehensive
Active Research Program
52.0
37
Active Research Program
52.0
38
NCI Comprehensive
Active Research Program
52.0
39
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
52.0
40
NCI Comprehensive
Active Research Program
52.0
41
Active Research Program
52.0
42
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
52.0
43
Active Research Program
52.0
44
NCI Comprehensive
Active Research Program
52.0
4552.0
46
Active Research Program
52.0
47
Active Research Program
52.0
48
Active Research Program
52.0
49
Active Research Program
52.0
50
Active Research Program
52.0
51
NCI Comprehensive
Active Research Program
36.8
52
NCI Comprehensive
Active Research Program
36.8
53
NCI Comprehensive
Active Research Program
36.8
54
NCI Comprehensive
Active Research Program
36.8
55
NCI Comprehensive
Active Research Program
36.8
56
NCI Comprehensive
Active Research Program
36.8
57
NCI Comprehensive
Active Research Program
36.8
58
NCI Comprehensive
Active Research Program
36.8
59
NCI Comprehensive
Active Research Program
36.8
60
NCI Comprehensive
Active Research Program
36.8
61
NCI Comprehensive
Active Research Program
36.8
62
NCI Comprehensive
Active Research Program
36.8
63
NCI Comprehensive
Active Research Program
36.8
64
NCI Comprehensive
Active Research Program
36.8
65
NCI Comprehensive
Active Research Program
36.8
66
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
36.8
67
NCI Comprehensive
Active Research Program
36.8
68
NCI Comprehensive
Active Research Program
36.8
69
NCI Comprehensive
Active Research Program
36.8
70
NCI Comprehensive
Active Research Program
36.8
71
NCI Basic_laboratory
Active Research Program
36.8
72
Active Research Program
36.8
73
Active Research Program
36.8
7436.8
75
Active Research Program
36.8
76
Active Research Program
36.8
77
Active Research Program
36.8
78
Active Research Program
36.8
79
Active Research Program
36.8
8028.4
81
BC CancerVancouver, BC

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →